三次性ポリフォスファート-トロンビン-フィブリン複合体の形成は,トロンビンの活性を弱める
Xintong Yao1, James C Fredenburgh2, Jeffrey I Weitz3
1Thrombosis and Atherosclerosis Research Institute and Hamilton General Hospital, Hamilton, Ontario, Canada; Department of Medical Sciences, McMaster University, Hamilton, Ontario, Canada.
Journal of thrombosis and haemostasis : JTH
|February 18, 2026
まとめ
血小板ポリフォスファート (polyP) は,トロンビンとフィブリンと複合体を形成し,ヘパリンと似ています. この複合体は,トロンビンを阻害から保護するが,線維素生成能力を低下させ,凝固に影響を与える.
科学分野:
- バイオケミストリー バイオケミストリー
- 血液学 ヘマトロジ
- 分子生物学は分子生物学である.
背景:
- 血小板由来ポリフォスファート (polyP) は,血栓凝固剤として作用し,トロビン生成とフィブリン形成を促進します.
- PolyPはヘパリンと同様に,トロンビンとフィブリンと相互作用します.
研究 の 目的:
- ヘパリンに似たポリPが,トロンビンがフィブリンと結合することを促進するかどうかを調査する.
- この相互作用が,トロンビン活性を調節する三元的なポリP-トロンビン-フィブリン複合体を形成するかどうかを判断する.
主な方法:
- ラベル付けされたポリアニオンを使用して,ポリPとヘパリンの繊維素に対する親和性を評価した.
- クロモゲン解析によるポリアニオンとポリアニオンなしの量化トロンビン・フィブリン相性.
- ポリアニオンとフィブリンの存在下でのアンチトロンビン-ヘパリンによるトロンビン抑制率の測定.
主要な成果:
- PolyPとヘパリンは,高い親和性 (Kd ≈1.7 μMと1.1 μM,それぞれ) でフィブリンと結合する.
- ポリPまたはヘパリンがある場合,トロンビンはフィブリンと結合し,その欠席 (Kd ≈ 5.6 μM) と比較して, afinity (Kd ≈ 1.2 μM と 0.9 μM) が著しく増加します.
- 三重複合体は,抗トロンビン-ヘパリン阻害からトロンビンを保護するが,そのフィブリン誘発活性を低下させる.
結論:
- PolyPは,ヘパリンの作用を反映した三元複合体の形成 (polyP-トロンビン-フィブリン) を促進します.
- この複合体は,トロンビンを阻害から守りますが,フィブリン生成におけるプロコアグラント機能を低下させます.
- 発見は,血静性におけるポリP,トロンビン,およびフィブリンの調節作用を明らかにしています.
関連する概念動画
01:16Clot Retraction and Fibrinolysis
9.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.4K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
13.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.7K
01:30Venous Thrombosis I: Introduction
519
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
519
01:09Coagulation
11.0K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.0K
01:22Formation of the Platelet Plug
9.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.8K